← FDA Drug Approvals (Drugs@FDA)

NIMODIPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2025-01-22

Drug application

FDA Application #

ANDA213409

Application type

Abbreviated New Drug Application (Generic)

Brand name

NIMODIPINE

Generic name

Nimodipine

Active ingredients

NIMODIPINE

Dosage form

SOLUTION

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

ALKEM LABS LTD

First approval

2025-01-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown